Clover Health: Smart Money Should Be Accumulating Ahead Of 2026 GAAP Profits [Seeking Alpha]
Clover Health Investments, Corp. - Class A Common stock (CLOV)
Company Research
Source: Seeking Alpha
Clover's higher returning member mix and targeted growth measures aiming to bring more members under Clover Assistant quicker are major tailwinds to medical costs next year, in my opinion. Clover Assistant's early diagnosis capabilities set the company up to benefit from the CMS' Part D measures aiming to normalize cost pressures on plans, in my opinion. I'm estimating Clover's 2026 GAAP net income at $148.8 million. I'm reiterating my strong buy rating for Clover with a $5.76 price target by the end of 2026, implying 131% upside from its current valuation. Svetlana-Cherruty/iStock via Getty Images Since my last coverage , shares of Clover Health Investments, Corp. ( CLOV ) are down 34% as a result of disappointing Q3 earnings that saw a major spike in medical costs, leading the company to slash its This article was written by Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any s
Show less
Read more
Impact Snapshot
Event Time:
CLOV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CLOV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CLOV alerts
High impacting Clover Health Investments, Corp. - Class A Common stock news events
Weekly update
A roundup of the hottest topics
CLOV
News
- Clover Health (CLOV): Assessing Valuation as 2026 GAAP Profitability Becomes the Next Potential Turning Point [Yahoo! Finance]Yahoo! Finance
- Clover Health Investments (NASDAQ:CLOV) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.MarketBeat
- Clover Health Investments (NASDAQ:CLOV) had its "sell (d-)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Clover Health to Participate in Upcoming 2025 Citi Global Healthcare ConferenceGlobeNewswire
- Why Fast-paced Mover Clover Health Investments (CLOV) Is a Great Choice for Value Investors [Yahoo! Finance]Yahoo! Finance
CLOV
Earnings
- 11/4/25 - In-Line
CLOV
Analyst Actions
- 11/6/25 - Canaccord Genuity
CLOV
Sec Filings
- 11/18/25 - Form 4
- 11/12/25 - Form 4
- 11/12/25 - Form 8-K
- CLOV's page on the SEC website